Early decreased plasma levels of factor B and C5a are important biomarkers in children with Kawasaki disease.

about

Early decreased plasma levels of factor B and C5a are important biomarkers in children with Kawasaki disease.

Item

http://www.wikidata.org/entity/Q40979777

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Early decreased plasma levels ...... hildren with Kawasaki disease.

@en

type

Item

label

Early decreased plasma levels ...... hildren with Kawasaki disease.

@en

prefLabel

Early decreased plasma levels ...... hildren with Kawasaki disease.

@en

P1476

Early decreased plasma levels ...... hildren with Kawasaki disease.

@en

P2093

Jin Fu

http://www.w3.org/2001/XMLSchema#string

Lin Shi

http://www.w3.org/2001/XMLSchema#string

Ming-Ming Zhang

http://www.w3.org/2001/XMLSchema#string

Nan-Ping Xu

http://www.w3.org/2001/XMLSchema#string

Qing-Mei Zou

http://www.w3.org/2001/XMLSchema#string

Rui-Xia Song

http://www.w3.org/2001/XMLSchema#string

Ting Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Dai Cui

http://www.w3.org/2001/XMLSchema#string

Xiao-Hui Li

http://www.w3.org/2001/XMLSchema#string

Yao Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ

Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function

Complement activation in diseases presenting with thrombotic microangiopathy.

Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management.

Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease

Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia.

Function and regulation of the complement system in cardiovascular diseases.

Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.

Endothelial dysfunction in children within 5 years after onset of Kawasaki disease.

Classical pathway complement activation in Kawasaki syndrome.

P2888

pr.2015.81

P304

205-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PR.2015.81

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25938736

http://www.w3.org/2001/XMLSchema#string

P921

biomarker